Factor VIII gene variants and inhibitor risk in African American hemophilia A patients.
Gunasekera D, Ettinger RA, Nakaya Fletcher S, James EA, Liu M, Barrett JC, Withycombe J, Matthews DC, Epstein MS, Hughes RJ, Pratt KP; Personalized Approaches to Therapies for Hemophilia (PATH) Study Investigators.
Gunasekera D, et al. Among authors: pratt kp.
Blood. 2015 Aug 13;126(7):895-904. doi: 10.1182/blood-2014-09-599365. Epub 2015 Jan 23.
Blood. 2015.
PMID: 25617427
Free PMC article.